Search Results 3541-3550 of 26419 for oral

  1. Gastrointestinal Disorders Clinical Trials - Mayo Clinic Research

    GII is a condition that is defined as the failure of oral re-feeding after abdominal surgery. A Study of the Effect of the Vibrant Capsule on Gastric ...

  2. Alumni - Hematology and Medical Oncology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    ... oral presentation awarded the YIA Top Rated Abstract oral presentation at iwCLL 2019. Medical school: University of Missouri, Columbia School of Medicine ...

  3. Gregory A. Broderick, M.D. - Doctors and Medical Staff - Mayo Clinic

    He has served as an Oral Examiner for Urology Boards since 2020. Dr. Broderick was elected Trustee of the American Board of Urology (ABU). His six-year term ...

  4. Irinotecan (intravenous route) - Side effects & uses - Mayo Clinic

    Unless otherwise directed by your doctor, take 4 milligrams (mg) of loperamide (2 capsules or tablets, or 4 teaspoonfuls of the oral solution dosage form) for ...

  5. Hematology - Clinical trials

    ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

  6. Back in Control After Successful Incontinence Treatment - Mayo Clinic News Network

    "To have overactive bladder is very common. Many people start treatment with an oral medicine, but they may not know there are treatments beyond oral medication ...

  7. Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) - Mayo Clinic

    ... oral factor Xa or IIa inhibitors ≤ 24 h before procedure - Planned staged PCI within 30 days after index procedure. - Any planned surgeries within 30 days ...

  8. Developing a Non-invasive Test to Detect Intestinal Inflammation in Active Inflammatory Bowel Disease - Mayo Clinic

    Use of oral corticosteroids and unable or unwilling to stop use of oral corticosteroids within the previous two weeks and for the duration of the study.

  9. Shawna L. Ehlers, Ph.D., L.P. - Doctors and Medical Staff - Mayo Clinic

    Best of the Best Oral Presentation (role: co-mentor)American Psychosocial Oncology Society ... Best Abstract for oral presentationBlood and Marrow ...

  10. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    ... oral corticosteroid (OCS) dose ≤ 7.5 mg/day of prednisolone or equivalent, following standard induction regimen for at least 3 months and within 6 months ...